Last edition
News about
TruDiagnostic Introduces Organ-Specific Aging Analysis from SYMPHONYAge Algorithms
TruDiagnostic has developed epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.
AbbVie Announces Acquisition of Celsius Therapeutics
AbbVie has acquired Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease.
Emcure Plans for Expansion and New Acquisitions with Upcoming IPO
Emcure Pharmaceuticals has been planning to expand its business as the upcoming initial public offering (IPO) will give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions.
Orchid Pharma and Cipla to Launch Cefepime-Enmetazobactam in India
Orchid Pharma has launched its new drug, Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.
Alembic Pharmaceuticals Secures FDA Final Approval for Doxycycline Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Capsules, 40 mg.
Lupin Gets Tentative Approval from FDA for Olopatadine Hydrochloride Ophthalmic Solution
Lupin has received a tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 percent (OTC).
Formation Bio Bags USD 372 MM in Series D Funding
Formation Bio has raised USD 372 MM of Series D financing.
CASI Pharmaceuticals Plans to Submit IND Application For CID-103
CASI Pharmaceuticals, Inc. has planned to submit an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for CID-103 for the treatment of antibody-mediated rejection (AMR) in kidney transplant recipients by the end of 2024.
Cellares Signs Deal with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform
Cellares has announced that Kite will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle.
Glenmark and IADVL Raise Awareness Campaign to Support Vitiligo Patients in India
Glenmark Pharmaceuticals Ltd. has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), to unveil postcards & Calendars aimed at raising awareness.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy